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Flexible endoscopy involves the insertion of a long narrow flexible tube into the body for
diagnostic and therapeutic procedures. In the gastrointestinal (GI) tract, flexible
endoscopy plays a major role in cancer screening, surveillance, and treatment
programs. As a result of gas insufflation during the procedure, both upper and lower
GI endoscopy procedures have been classified as aerosol generating by the guidelines
issued by the respective societies during the COVID-19 pandemic—although no
quantifiable data on aerosol generation currently exists. Due to the risk of COVID-19
transmission to healthcare workers, most societies halted non-emergency and
diagnostic procedures during the lockdown. The long-term implications of stoppage
in cancer diagnoses and treatment is predicted to lead to a large increase in preventable
deaths. Robotics may play a major role in this field by allowing healthcare operators to
control the flexible endoscope from a safe distance and pave a path for protecting
healthcare workers through minimizing the risk of virus transmission without reducing
diagnostic and therapeutic capacities. This review focuses on the needs and challenges
associated with the design of robotic flexible endoscopes for use during a pandemic. The
authors propose that a few minor changes to existing platforms or considerations for
platforms in development could lead to significant benefits for use during infection control
scenarios.




On March 11th, the WHO (World Health Organization) declared COVID-19 caused by the
SARS-CoV-2 virus a pandemic. There have been over 94 million cases reported and over two
million fatalities worldwide (Johns Hopkins University Coronavirus Center, 2020) as of
January 2021. The main symptoms include fever, cough, change in smell or taste,
breathlessness, and weakness with many people also reporting gastrointestinal symptoms
such as abdominal pain, diarrhoea and vomiting. A small percentage develop acute respiratory
distress syndrome (ARDS) which can be fatal. Human-to-human transmission primarily occurs
through direct contact or droplets (Repici et al., 2020), with smaller droplets (often called
aerosols) having the potential to remain airborne for an extended period of time and thus travel
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much larger distances. This means they cannot be tackled
simply by physical distancing measures employed whereas
larger particles are immediately pulled down due to gravity
and risks can be mitigated with physical distancing measures.
Endoscopy is considered a high-risk procedure due to the
proximity of health care workers (HCW) to patients and the
potential for aerosol generation. Recent work has shown that
endoscopists without proper face protection such as a face visor
could be at an increased risk to bacterial pathogens (Johnston
et al., 2019). Many studies have since shown that a face visor is
also not adequate face protection from droplets (Akagi et al.,
2020). Studies from the SARS-CoV-2 outbreak have shown that
droplets could easily reach 6 ft (∼2 m) from an infected patient
thereby putting HCW in endoscopy units at risk (Wong et al.,
2004).
Conventional Endoscopy
Endoscopy is a procedure where organs and tissues inside the
body can be imaged and monitored using an endoscope. An
endoscope is a thin tube with a light source and camera, often
with additional tools, for example ultrasound or a working
channel for introduction of biopsy forceps or therapeutic
equipment. Endoscopy can be used for diagnostic
(visualisation and sampling) and therapeutic purposes such as
removing cancer tissue. An endoscope can be either rigid or
flexible; with flexible endoscopes offering a multitude of
advantages for navigation to target sites. Endoscopes can be
inserted through natural orifices like the mouth, anus or
urethra or via incisions made in the body. Flexible endoscopy
is often used as a diagnostic tool for many types of cancer and
diseases and thus plays a vital role in the management of multiple
malignancies. There are many different types of endoscopy from
bronchoscopy (monitoring the lungs) to hysteroscopy
(monitoring the uterus) and cystoscopy (monitoring the
bladder); however, for the purposes of this review we will limit
our focus to flexible gastrointestinal (GI) endoscopy. There are a
range of flexible GI endoscopies including
esophagogastroduodenoscopy (EGD–for assessing esophagus,
stomach, and duodenum), colonoscopy (for assessing the large
bowel), sigmoidoscopy (for the rectum and sigmoid colon),
endoscopic retrograde cholangiopancreatography (ERCP–for
assessing the biliary tree and pancreatic ducts), and
enteroscopy (for assessing the small intestine).
Colorectal cancer is the third most common cancer in the
world in terms of mortality and fourth most common in terms of
incidence reaching nearly two million cases and one million
fatalities in 2018 according to some projections (Rawla et al.,
2019). Colonoscopy can detect and remove pre-cancerous tissue
in the colon, thus preventing the development of colorectal
cancers. GI endoscopies are also the gold standard
investigative method in the diagnosis and surveillance of a
large variety of conditions such as celiac disease, and
inflammatory bowel diseases. In 2014, it was projected that
there will be over 75 million gastrointestinal endoscopic
procedures performed by 2020 in Europe and the
United States alone (Lau, 2014). There were more than two
million total GI procedures in the United Kingdom in 2019
(Ravindran et al., 2020) and over 17 million total GI
procedures in the United States in 2013 (Peery et al., 2019).
Conventional endoscopy uses a semi-rigid tube and
manoeuvring the endoscope is performed manually by
rotation of a set of wheels on the handle and by pushing,
pulling, and torqueing the insertion tube of the endoscope.
Many procedures are uncomfortable or painful, requiring
analgesia and sedation. A typical GI endoscopy process
requires multiple HCW inside the room–an endoscopist, an
assistant/technician, and a nurse to monitor the patient. For
general anaesthetic and fluoroscopic procedures, this could
potentially include anaesthesiologists and radiographers.
Typical pre-pandemic personal protective equipment (PPE) for
these processes consisted of gloves, gown/apron, and eye
protection.
COVID-19 Related Risks During Flexible GI
Endoscopy
Some endoscopic procedures are considered aerosol generating
procedures (AGPs). Aerosols are small particles/droplets below
5 µm that can remain airborne for an extended period of time.
One of the postulated sources of aerosol generation during
endoscopy procedures is related to gas insufflation. Positive
insufflation is used to visualize the lumen and create space to
move the instrument forward. The potential generation of
aerosols during endoscopy could pose a risk to HCW.
Evidence of aerosols generated during different endoscopic
procedures varies and there is no homogeneity of evidence.
Endoscopic procedures such as bronchoscopy have been
shown to be aerosol generating along with several other
patient care and operating room procedures (Mittal et al.,
2020; Thamboo et al., 2020; Wahidi et al., 2020). However, for
GI endoscopic procedures, no current evidence exists of aerosol
generation and advice from respective societies around infection
control (IC) is based on expert opinion (Chai et al., 2020;
Mahadev et al., 2020; Repici et al., 2020; Tse et al., 2020). A
well-designed study is needed to address this knowledge gap in
the field that would allow tailored advice for specific endoscopic
procedures.
Upper GI procedures are considered a greater risk during the
current pandemic because the virus has been shown to be
transmissible through airway secretions. The risk for lower GI
procedures (e.g. colonoscopy and sigmoidoscopy) is less clear,
although SARS studies have shown the presence of coronavirus in
stool samples and in intestinal biopsy samples (Isakbaeva et al.,
2004; Pan et al., 2020) and there is some data regarding the
dispersion of microorganisms throughout an endoscopy suite
during colonoscopy (Vavricka et al., 2010). There has also been
some focus on identifying a COVID-19 outbreak through
wastewater at several institutions in the United States, which
would suggest either the presence of the virus or viral RNA in
stool samples (Cahill andMorris, 2020). For now, most guidelines
from gastroenterology societies have classified all GI endoscopic
procedures as AGPs (Chai et al., 2020; Mahadev et al., 2020;
Repici et al., 2020; Tse et al., 2020). Therefore, PPE has been
enhanced during the COVID-19 pandemic to include a full sleeve
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gown, an FFP3/N95 mask, gloves, face visor or goggles, shoe
covers, and a surgical hair cap.
Potential for Innovation
Despite significant advances in the imaging capabilities of
endoscopes, the controls remain largely unchanged in the last
60 years. The rear steering approach of conventional colonoscopy
for example stretches the bowel and surround mesentery which
makes it uncomfortable and often requires sedation or analgesia.
While many new devices are being developed to attempt to
address the shortfalls of conventional endoscopy (Table 1),
COVID-19 has further highlighted the need for innovation in
the field of flexible endoscopy. One such improvement is the use
of disposable endoscopes that have already gained popularity due
to concerns around duodenoscope related infection and infected
biofilm in endoscope channels (Rauwers et al., 2018; Balan et al.,
2019). There is also a considerable argument for a single use
endoscope in reducing the running costs of departments by
preventing the need for costly decontamination facilities and
supplies (Larsen et al., 2020). The current pandemic has increased
the awareness of IC, and the time has come to explore single use
endoscopes further.
Another avenue of improvement in endoscopy is through
robotic advancements, which have the potential to reduce pain
and widen the availability of procedures as they often place a
lower cognitive and physical (improved ergonomics) burden on
the operator and thus require less training. Robotic flexible
endoscopy (RFE) can offer many advantages in general and
specifically when dealing with IC related to aerosol generation.
During the time of COVID-19, these include introducing physical
distancing between HCW and patients (enabled as a result of
teleoperation) as well as reduce the number of HCW in the
endoscopy suite. In this review, we explore the impact of COVID-
19 on GI endoscopy processes and how robotic flexible
endoscopic platforms can be designed to minimize these
impacts and improve IC mechanisms.
IMPACT OF COVID-19 ON FLEXIBLE GI
ENDOSCOPY
Reduction of GI Endoscopic Capacity and
Its Long-Term Implication
Due to COVID-19 guidance, endoscopic procedures were
significantly reduced during the pandemic to acute, urgent
cases. In Europe, the volume of these procedures fell to 15%
of previous capacity between February to May 2020 during the
peak of the pandemic, while in North America, these levels were
at 10% (Parasa et al., 2020). The National Endoscopy Database
(The National Endoscopy Database, 2020) shows that endoscopic
procedures fell to about 5% of normal levels in the
United Kingdom. They were down from about 35,000
reported procedures per week to 1,700 for the week ending
April 13th, 2020. When compared to 2019 levels in the
TABLE 1 | Examples of robotic flexible endoscopy (RFE) platforms.
Device Actuation and features Outcome
of clinical studies
Aer-O-Scope system (GI view, ramat Gan, Israel)
(Pfeffer et al. (2006); Gluck et al. (2016))
Two cameras, one front viewing and second giving a 360°
panoramic view that can see behind folds, disposable,
tip-pulling locomotion, computer aided control, no
steering or instrument channel
Cecal intubation was successful in 55/56 recruited
patients (98.2%). System detected 87.6% of polyps.
No mucosal damage or adverse events were reported.
Available on the market.
Neo-guide endoscopy system (NeoGuide endoscopy
system Inc., Los Gatos, CA, United States) (Eickhoff
et al. (2007))
Electromechanical actuation of 2 independent 2 DOF
segments to achieve snake - like motion, shape retention,
instrument channel, 3D map of the device, computer-
aided control, reusable so requires cleaning, large
diameter
Cecal intubation was successful in 10 patients in the
time range 24–60 min.
No longer available on the market.
Invedosacope TMSC40 (Invendo medical GmbH,
Weinheim, Germany and AMBU A/S, Copenhagen,
Denmark) (Rosch et al. (2008); Groth et al. (2011);
Yeung et al. (2019))
Disposable colonoscope (10 mm in diameter, with a 3.1-
mm working channel), controlled electro-hydraulically by
actuators placed outside the patient, operator controlled
with a joystick interface, disposable, instrument channel,
diameter similar to a colonoscope
Cecal intubation was successful in 98.4%, reported to
be painless in 92% of patients.
No longer available on the market.
Endotics (ERA endoscopy SRL, Peccioli, Italy)
(Cosentino et al. (2009); Tumino et al. (2010); Tumino
et al. (2017))
Inchworm movements, disposable, steerable tip with
integrated camera and light source, computer-aided
control, thin tip, no instrument channel, and procedure
times longer than colonoscopy
Significantly lower patient discomfort and was also able
to complete 93% of colonoscopies that were left
incomplete through conventional colonoscopy
Available on the market.
Consis medical (Beer’Sheva, Israel) (Yeung et al.
(2019))
Consists of an inverted sleeve that self-propels through
the colon using hydraulic aided propulsion. The sleeve is
disposable, while the device head is a capsule that can be
sterilised.
No available clinical studies
NaviCam
®
(Ankon technologies co, Ltd. Wuhan,
Shanghai, China) (Liao et al. (2016))
A wireless capsule endoscope that can be actuated
internally by an external magnetic field.
Mean duration of examination was 25 ± 7 min. Anxiety,
discomfort and pain scores (worst-best  0–10) were
1 ± 0, 1.3 ± 0.6, and 1 ± 0 respectively.
Magnetic flexible endoscope (MFE)(STORM Lab,
Leeds, United Kingdom/Nashville, TN, United States)
(Martin et al. (2020))
Relies on actuation using a permanent magnet
manipulated by a robot that is external to the patient; no
push activation, instrument channel, large one-time robot
cost and complexities around magnetic control
Currently undergoing human trials
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United Kingdom, 51% more people were waiting for
colonoscopies, 46% more for flexible sigmoidoscopies and 44%
more patients were waiting for gastroscopies as of July 2020
(Cancer Research UK, 2020). While these numbers are
specifically focused on the United Kingdom, a similar trend
was seen worldwide in almost every national healthcare
system. The statistics in this review are sometimes focused on
the United Kingdom and United States as these are just a result of
easily accessible data. It is estimated that for every week that
screening is paused, 7,000 people are not being referred for
further tests and 380 cancers are not being diagnosed through
screening programs in the United Kingdom (Roberts, 2020).
Avoidable deaths due to suspended screening and treatment
are expected to rise significantly with an estimated increase of
more than 6,000 excess deaths in the United Kingdom and more
than 33,000 excess deaths in the US (Lai et al., 2020). Endoscopic
capacity has still not been restored to pre-pandemic levels (at 80%
in September 2020) and with a second wave imminent, it becomes
important to set the scene for future IC measures and to
understand how RFE can service this need.
Current endoscopic procedures rely on PPE (enhanced during
COVID-19), comprehensive room and equipment cleaning and of
course air circulation (Garbey et al., 2020) which can vary for
endoscopy suites. Despite concerns around patient exposure to the
virus due to contaminated endoscopes, evidence suggests that
reprocessing agents with viricidal activity will remove the SARS-
CoV-2 virus (Kampf et al., 2020; Rai, 2020). In the past, certain
bacteria were not successfully removed from duodenoscopes
(Rauwers et al., 2018; Balan et al., 2019), starting a push for
disposable endoscopes. There is some evidence of bronchoscope
contamination (Ofstead et al., 2020), and therefore single-use
endoscopes are considered safer, with potential cost savings in the
long run from not having large-scale cleaning facilities on premises.
Other Infection Control Measures
Another IC technique has been to adapt the current facilities such
as the endoscopy suite to increase safety during the COVID-19
pandemic. Modified face masks or boxes have been developed as
mechanical barriers (Narwani et al., 2020; Tsui, 2020). Paired with
CO2 extractors or suction mechanism, they create negative
pressure zones with the potential of eliminating (or significantly
reducing) aerosols escaping the procedure site and travelling
around the suite. None of the mentioned risk minimizing
techniques have been quantified and the evidence around
aerosol dispersion while using these methods has not been
published. There is a clinical need to quantify aerosol
generation during standard flexible endoscopic procedures as
well as robot assisted approaches. Apart from that, there is a
need for evaluation of mechanical barriers and extractors currently
employed in the hospitals to provide best and uniform guidelines
for clinicians working during a pandemic. Air filtration is another
key aspect in reducing HCW exposure to any potential aerosols
(Garbey et al., 2020).
The Ideal RFE
A flexible robotic endoscopic platform must be able to meet
certain needs during COVID-19. A teleoperated platform would
allow physical distancing between the patient and HCW. A
simple and easy to use robotic platform could reduce the
number of people in the room allowing reallocation of staff at
a crucial time and putting fewer HCW at risk during each
procedure. A less painful procedure which does not require
sedation would also reduce the number of people in the room.
More intuitive navigation will reduce training times for future
endoscopists. A RFE platform would preferably have higher
degrees-of-freedom (DOF) than current commercial platforms
and improved control. In addition, AI systems can be used for
improved navigation and localization of endoscopes using data
from both imaging and on-board sensing. This increased control
and better visibility of the intestine would improve detection rates
while allowing procedures such as tissue sampling and cancer
removal to be performed. By reducing the force and torque
exerted on the luminal wall, patient discomfort can be reduced
in addition to sedation requirements thus lowering risk and
recovery times. Finally, it is important to consider the
environmental impacts of single-use endoscopes and using
recyclable materials would be beneficial for future platforms.
ROBOTIC FLEXIBLE GI ENDOSCOPY
The motivation for developing robotic platforms in endoscopy is
similar to the motivation in other biomedical areas such as
robotically assisted surgery. These robotic platforms allow
HCW to overcome the current limitations of standard
endoscopic devices for diagnostic and therapeutic procedures.
These platforms can be used to improve the precision and safety
of the tools thus making them more reliable and effective
(Boškoski and Costamagna, 2019). The challenges for these
platforms are around locomotion of endoscopes and
instrument control as well as their applicability to a wide
variety of clinical applications. RFE has the potential to
increase safety of procedures by lowering risk of tissue damage
due to human error and lower the rates of complications.
RFE has the potential to meet the needs of enhanced IC
measures during COVID-19 and future pandemics. Remotely
controlled devices increase the distance between patient and
operator, hence less aerosol and droplet contact and reduced
infection risk for HCW (Wong et al., 2004). Easy to operate
robotic platforms could also help to reduce the HCWs in the
room and reduce training times. It could also be extremely useful
in cases where precise finemotor skills are required and cannot be
met by normal human dexterity by improving the control and
precision of endoscopes in robotic platforms (Lucarini et al.,
2015). This will improve the speed and accuracy of procedures
which will reduce adverse effects and discomfort during the
procedure. Both will result in patients spending less time in
the endoscopy suite.
Advantages of RFE
With the potential advantage of lowering discomfort for patients,
RFE can be used in cases where the patient is unable to tolerate
conventional endoscopy or in cases where frailty and co-
morbidity rule out the use of sedation during conventional
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endoscopy procedures. This will be achieved by having precise
control over the force and torque applied to the luminal walls
through force feedback. It will be hugely beneficial in cases where
patients require repeated and regular procedures (e.g. surveillance
in those with inflammatory bowel disease, or hereditary colorectal
cancer) where using a less painful procedure will enhance
surveillance uptake. It can also help to improve detection rates
as more control and more comfort means better visibility.
Another gap that RFE could fill is in cases where conventional
endoscopes are unable to complete an examination.
While RFE is a potential solution for diagnostic endoscopy
and therapeutic procedures in the GI tract, challenges remain due
to the limited DOF of such platforms. Therefore, current RFE
research focuses on increasing the manoeuvrability and control of
the tools to enable more complex and varied interventions.
Flexible endoscope manipulations common to most systems
are shaft insertion and tip steering. These complex movements
add difficulty in developing robot-assisted flexible endoscopes.
Examples of RFE
Over the years many researchers have developed RFE platforms
focused on various actuation and control approaches. There are
several recent reviews (Li et al., 2007; Ciuti et al., 2016; Tapia-Siles
et al., 2016; Li and Chiu, 2018; Boskoski and Costamagna, 2019;
Ciuti et al., 2020; Visconti et al., 2020) that cover these
technologies and other cutting-edge platforms in depth which
is not the remit of this paper. A selection of them are listed in
Table 1. The Bellowscope is another promising device not
included in the table since it is not strictly a robotic platform
but is a low-cost disposable endoscope. Its working principle is
based on pistons and bellow actuators which are controlled by
multi-DOF handheld controller (Garbin et al., 2018a; Garbin
et al., 2018b; Garbin et al., 2019; Chandler et al., 2020).
Wireless endoscopes (capsules) are a great tool for diagnostic
purposes and providing painless inspection of the GI tract.
Introduction through the mouth and lack of wiring makes
them ideal for diagnostic applications (Liao et al., 2016). The
less invasive a procedure is; the less risk it carries, more so in the
current climate. Currently available capsules can visualize the
small bowel (such as the PillCam (Li et al., 2007)) and therefore
have good diagnostic capabilities but lack therapeutic capabilities.
Capsules for upper GI tract are more difficult but some devices
with handheld magnetic control have shown some promise, again
solely for diagnostic use. The best technical solution at the
moment is the NaviCam® (Ankon Technologies Co, Ltd.
Wuhan, Shanghai, China), with a wireless capsule endoscope
steered magnetically inside the stomach filled with water (Jiang
et al., 2019). This can be classified as a robotic solution as there is a
robotic arm moving the magnetic field generator. This is in use in
almost every large hospital in China. The colon capsule, however,
is less successful. Without the ability to clean the stool coating the
mucosa the views are limited. In addition, up to 50% of people
will have a pathology requiring biopsy and therefore, many end
up requiring conventional colonoscopy anyway. While capsule
endoscopes would have major advantages in the case of
aerosolized particles (Slawinski et al., 2015; Ciuti et al., 2016);
they still have severe limitations for GI endoscopy. They lack the
ability to take biopsy samples or perform therapeutic procedures.
The requirements for a perfect capsule would include enhanced
locomotion, location, vision, telemetry, energy, and diagnostic
and therapeutic tools. A further limitation is including all these
technologies in a capsule that is small enough to safely traverse
the GI tract (Kwack and Lim, 2016; Singeap et al., 2016).
CHALLENGES FOR ROBOTIC FLEXIBLE GI
ENDOSCOPY TO OVERCOME DURING
COVID-19
RFE can introduce physical distancing into the endoscopy units.
However, one of the main challenges is related to feeding and
manoeuvring the flexible endoscope. Endoscopists can be
severely limited due to a lack of manoeuvrability when
manually operating the endoscopes during both diagnostic and
therapeutic procedures. It has been documented that during the
removal of abnormal tissue (polyps) during colonoscopies, even
well-experienced endoscopists can miss up to 20% of the tissue
(van Rijn et al., 2006). Robotic platforms use various actuation
mechanisms for endoscopes with varying levels of
manoeuvrability. In fact, in many review papers, robotic
endoscopes are classified based on their actuation principles
which typically fall into one of the following categories: 1)
magnetic, 2) electric or 3) hydraulic or pneumatic with many
devices using a combination of these principles. For example: a
legged robotic endoscope has recently been developed (Lee et al.,
2017; Lee et al., 2019) that can be operated with an electric motor
connected to reel-based mechanism that is both simple and
reliable. By using soft materials for the legs, a high degree of
manoeuvrability was achieved with no scratches or perforations
on a porcine tissue. This is just one example of how robotic
endoscopes in development can solve some of the current
challenges.
Another challenge is related to operating an endoscopic
instrument through the working channel, making sure that no
aerosols come back from that channel. The working channel of
the endoscopes can be responsible for releasing aerosols or
droplets into the suite during standard operating procedure
(Vavricka et al., 2010). However, very little quantifiable data
exists around whether this is an issue and how big of a challenge it
could be. A study that measures the aerosol levels in GI
endoscopy suites during procedures would be a welcome
addition to the field as well as a follow-up comparison with
robotic platforms.
Introducing robotic platforms to endoscopic systems
simplifies the procedure. Teleoperation allows clinicians to
control the endoscope from a safe distance or/and behind
mechanical barriers, with reduced need for direct contact with
the patient. Reduced discomfort means less monitoring is
required and no need for additional anaesthesiologists or
nursing staff, thus reducing the risk to HCW as can be seen in
Figure 1.
Following evidence of transmission of infection despite
decontamination, via infected biofilm in endoscopes (Rauwers
et al., 2018; Balan et al., 2019), single use endoscopes are
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gaining popularity (Pfeffer et al., 2006; Rosch et al., 2008; Cosentino
et al., 2009; Tumino et al., 2010; Groth et al., 2011; Gluck et al.,
2016; Tumino et al., 2017; Yeung et al., 2019). For example: the
Aer-O-Scope proposes RFE with disposable rectal introducer and
supply cables for colonoscopy (Pfeffer et al., 2006; Gluck et al.,
2016). Research on fully disposable endoscopes with robotic
platforms should be prioritized to implement these solutions in
hospitals during the COVID-19 pandemic or future airborne virus
pandemics. Single use conventional endoscopes are becoming
commercially available. An alternative to disposable endoscopes
is tool protection (e.g. protective sheet) which can be disposed of
after the procedure, followed by routine sterilisation of the
remaining part. However, decontamination of endoscopy
equipment is costly, and additionally places more HCW at risk
of contraction of infections such as coronavirus during the
decontamination process. There is evidence that some tools,
such as bronchoscopes (Ofstead et al., 2020) and
duodenoscopes (Rauwers et al., 2018; Balan et al., 2019), might
still be contaminated with bacteria after routine sterilization.
Recurrent passing of instruments down the working channel of
the scope leads to damage, that damage leads to accumulation of
biofilm which can become infected (Alfa and Singh, 2020; Bouiller
et al., 2020; Santos et al., 2020).
DISCUSSION
RFE procedures have the potential to be completed with increased
speed and without sedation and fewer complications, leading to a
shorter recovery time, freeing space in endoscopy suites at a
crucial time where endoscopic capacity has still not recovered to
pre-pandemic levels. GI endoscopic procedures have been
deemed high risk of contact and droplet formation with the
potential to be aerosol generating. Despite little evidence as of
now as to the true aerosol generating potential of GI endoscopic
procedures, enhanced IC measures are likely to continue.
The ideal RFE during COVID-19 would combine
teleoperation, single-use endoscopes and mechanical barriers/
seals. Teleoperation allows for physical distancing between
patients and HCW, single-use endoscopes would reduce the
risk of contaminated scopes. A mobile device would also be
extremely useful at a time when the endoscopy suite capacity
is limited to make space for COVID-19 patients. RFE has
significant potential in diagnostic and therapeutic endoscopy,
but some challenges remain to developing the ideal pandemic-
secure RFE. There is a significant need for a study to define the
aerosol generation during GI endoscopy in order to tailor future
guidance for both patients and HCW and maintaining capacity
levels in order to avoid devastating long term implications. Even
with the hope of a successful vaccine rollout, we have learned that
healthcare technologies should be resilient to pandemics in
general, so we believe this review will still be relevant in the future.
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Boškoski, I., and Costamagna, G. (2019). Endoscopy robotics: current and future
applications. Dig. Endosc. 31 (2), 119–124. doi:10.1111/den.13270
Bouiller, K., Ilic, D., Wicky, P. H., Cholley, P., Chirouze, C., and Bertrand, X.
(2020). Spread of clonal linezolid-resistant Staphylococcus epidermidis in an
intensive care unit associated with linezolid exposure. Eur. J. Clin. Microbiol.
Infect. Dis. 39 (7), 1271–1277. doi:10.1007/s10096-020-03842-7
Cahill, N., and Morris, D. (2020). Recreational waters – a potential transmission
route for SARS-CoV-2 to humans?. Sci. Total Environ. 740, 140122. doi:10.
1016/j.scitotenv.2020.140122
Cancer Research UK (2020). 44% rise in patients waiting for tests to diagnose bowel,
stomach, bladder and oesophageal cancer. London, United Kingdom: Cancer
Research UK.
Chai, N., Mei, Z., Zhang, W., Du, C., Wang, X., Li, L., et al. (2020). Endoscopy
works during the pandemic of coronavirus COVID-19: recommendations by
the Chinese Society of Digestive Endoscopy.United European Gastroenterol. J. 8
(7), 798–803. doi:10.1177/2050640620930632
Chandler, J. H., Chauhan, M., Caló, S., Aruparayil, N., Garbin, N., Campisano, F.,
et al. (2020). Tu1964 usability of a novel disposable endoscope for gastric cancer
screening in low-resource settings: results from rural India. Gastroenterology
158 (6), 1235. doi:10.1016/S0016-5085(20)33749-5
Ciuti, G., Caliò, R., Camboni, D., Neri, L., Bianchi, F., Arezzo, A., et al. (2016).
Frontiers of robotic endoscopic capsules: a review. J. Microbio. Robot. 11 (1),
1–18. doi:10.1007/s12213-016-0087-x
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